Luye Pharma’s innovative drug enters final stage of NDA Process

Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovativ...

December 31, 2018 | Monday | News
OUE Lippo's JV to manage three medical facilities in China

Singapore – OUE Lippo Healthcare Limited announced that its 50:50 joint venture company with China Merch...

December 31, 2018 | Monday | News
InventisBio, Betta Pharma collaborate for Non-Small Cell Lung Cancer drug

InventisBio announced that it has signed a "Collaboration Agreement" with Betta Pharma.  Under this agreement, Inve...

December 28, 2018 | Friday | News
MEDI FUTURES raises US$5M through common stocks

MEDI FUTURES, a biomedical ultrasound company and a member company of the K-ICT Born2Global Centre, successfully at...

December 28, 2018 | Friday | News
JHL Biotech declares Phase III Study of JHL1101

JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...

December 28, 2018 | Friday | News
Innovent, Eli Lilly announce co-development of Tyvyt

Innovent Biologics and Eli Lilly and Company have jointly announced that the co-developed Tyvyt (fully human anti-PD-1 t...

December 28, 2018 | Friday | News
ICSE China 2019 helps enterprises seize new industry opportunities

ICSE China 2019, hosted by CCCMHPIE, UBM EMEA, and UBM Sinoexpo, will take place again in Hall E2/E7...

December 27, 2018 | Thursday | News
Xynomic Pharma acquires global exclusive rights for Boehringer Ingelheim's cancer drug

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company has announced that it has bee...

December 26, 2018 | Wednesday | News
I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...

December 24, 2018 | Monday | Company results
Xynomic acquires cancer candidate from Boehringer for $800 M

Xynomic Pharmaceuticals, Inc., a clinical stage US-China oncology drug development company, has been granted an exclusiv...

December 21, 2018 | Friday | News
Gan & Lee enters into licensing agreement for insulin analogs

Gan & Lee Pharmaceuticals (Gan & Lee), an industry leading biopharmaceutical company with 20 years’ experi...

December 20, 2018 | Thursday | News
Align reaches 6M Invisalign patient milestone from China

Singapore - Align Technology announced that over 6 million patients have begun treatment with Invisalign - the most...

December 19, 2018 | Wednesday | News
Pall opens Biotech integrated solutions Centre in China

Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a ...

December 19, 2018 | Wednesday | News
Cellular Biomedicine Group Appoints CAR-T Pioneer as Member of Scientific Advisory Board

  Cellular Biomedicine Group, a biopharmaceutical firm engaged in the development of immunothera...

December 18, 2018 | Tuesday | News
FibroGen's roxadustat OK'd in China

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...

December 18, 2018 | Tuesday | News
2019 ENMORE BIO CONFERENCE set to host biotech industry in China

Singapore - 2019 ENMORE BIO CONFERENE will be held on 1st-3rd, March, 2019 in Nanjing Young Cultural Center, Nanjing, Ch...

December 18, 2018 | Tuesday | News
Mobidiag announces JV with Autobio Diagnostics

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, has e...

December 18, 2018 | Tuesday | News
I-Mab partners with CSPC for long-acting GLP-1 Fc Program

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company focused on the development of innov...

December 17, 2018 | Monday | News